Biotechnology
Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa
EAST RUTHERFORD, N.J., Oct. 27, 2022 /PRNewswire/ -- Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis...
Tsinghua SIGS Virtual Open Day 2023 | Where your future starts
Attending an Open Day is a great opportunity to find out about the postgraduate programs we offer. Watch information sessions delivered by our faculties and get a deeper insight into our excellent programs. We are for you to provide all the information you want, including how we can help build yo...
Antengene to Host Research and Development Day on November 15th and 17th, 2022
* Virtual English Session: Tuesday, November 15 at 8:30 AM – 12:00 PM Eastern Time November 15 at 9:30 PM – November 16 at 1:00 AM Beijing Time * Hybrid Mandarin Session in Shanghai: Thursday, November 17 at 1:30 PM – 5:30 PM Beijing Time SHANGHAI and HONG KONG, Oct. 26, 2022 /PRNewswire/ -- An...
Telix Recognised as Company of the Year at AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards 2022
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is today pleased to announce that it has been awarded Australian Company of the Year in the 2022 AusBiotech and Johnson & Johnson Innovation Industry Excellence Awards, held today at t...
Cali Biosciences Announces Publications of Phase IIa Results of Long-Acting Ropivacaine (CPL-01)
CPL-01, for Non-Opioid Treatment of Post-Operative Pain, Garners Publication of Clinical Data in Abdominoplasty and Presentation of Preclinical Data in Bony and Soft-Tissue ModelsSupporting Pharmacokinetics and Safety SAN DIEGO, Oct. 26, 2022 /PRNewswire/ -- Cali Biosciences Co., Ltd. (hereinaft...
Forsea Attracts USD5.2M to Expand Cultivated Seafood, Without Harming Sea Life
Start-up pioneers organoid technology to make nature identical, cultured eel meat at cost parity REHOVOT, Israel, Oct. 27, 2022 /PRNewswire/ -- Forsea Foods, Ltd., a FoodTech start-up, is the first company to use organoid technology for culturing seafood products. With a goal of redressing the d...
SUCCESSFUL PASSING OF EU QP AUDIT ON TOT BIOPHARM'S COMMERCIAL PRODUCTION BASE FOR MONOCLONAL ANTIBODY DRUG SUBSTANCES AND ANTIBODY DRUG CONJUGATES
SUZHOU,China, Oct. 27, 2022 /PRNewswire/ -- TOT BIOPHARM International Company Limited (TOT BIOPHARM, Stock code: 1875.HK) has recently received a GMP compliance inspection report approved by aQualified Person ("QP") in the European Union ("EU") in respect of the manufacturing facilities and asso...
JW Therapeutics and 2seventy bio Announce Strategic Partnership to Accelerate the Research and Development of T Cell-based Immunotherapies
* Initial focus on accelerating development of 2seventy's MAGE-A4 program in solid tumors inChina SHANGHAI, China and CAMBRIDGE, Mass., Oct. 27, 2022 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and comme...
Samsung Biologics Reports Third Quarter 2022 Financial Results
* Recorded consolidated revenue of KRW 873 billion in Q3'22 * Recorded consolidated operating profit of KRW 324.7 billion in Q3'22 * Started partial operations at Plant 4 within 23 months since groundbreaking as previously committed and launched two new development platforms INCHEON, South K...
Telix and UniQuest to Collaborate on Radiolabelled Immune Targeting Peptide
MELBOURNE, Australia, Oct. 27, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces a collaboration with UniQuest Pty Ltd (UniQuest), the commercialisation company of TheUniversity of Queensland (UQ), to develop a radiolabelled molecule targeting an im...
Alterity Therapeutics Announces Presentation of MRI Data from the bioMUSE Natural History Study at the American Neurological Association Annual Meeting
MELBOURNE, Australia and SAN FRANCISCO , Oct. 26, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced a poster presentation f...
WuXi AppTec Reports Record Year-to-Date Results in 2022, Third Quarter Revenue over RMB10 Billion
Revenue Up 71.9% Year-Over-Year to RMB28,395 Million Net Profit Attributable to Owners of the Company Up 107.1% Year-Over-Year to RMB7,378 Million Diluted Earnings Per Share (EPS) Up 90.1% Year-Over-Year to RMB2.30 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 77.9% Year...
Meet the female scientists who develop cellular and gene therapies
SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- Inside Namtai Inno Park in Guangming District hides a low-profile biomedical development firm – Shenzhen Wingor Biotechnology Co. Upon entering the company, one may feel a different vibe – something gentle yet vibrant, maybe because it's female-domin...
First satellite bioanalytical lab offers fastest option for PBMC processing in Australian clinical trials
THEBARTON, Australia, Oct. 26, 2022 /PRNewswire/ -- On 09 September 2022, Australia welcomed its first bioanalytical laboratory inside a Phase 1 clinical unit. Agilex Biolabs, Australia's largest bioanalytical laboratory, has established its first satellite processing unit on the fifth floor o...
ImmVira announced its signing of Series C+ financing and negotiation with further investors for the round
SHENZHEN, China, Oct. 26, 2022 /PRNewswire/ -- ImmVira announced its successful signing of Series-C+ financing transaction documents with the first batch of investors recently. This round of financing was initiated by China Merchants China Direct Investments Limited with participation of Lifebay ...
Alwin Capital's New Dual-Currency Fund Closed and Exceeded Fundraising Target
BEIJING, Oct. 25, 2022 /PRNewswire/ -- Alwin Capital recently closed a new
dual-currency fund, raising overUS$300 million, which exceeds their fundraising
target.
Metabolon Advances the Understanding of Inflammation and Inflammatory Response with New Oxysterols Targeted Panel
The new targeted metabolomics panel provides absolute quantitation for important bioactive intermediaries of inflammation and disease pathogenesis MORRISVILLE, N.C., Oct. 25, 2022 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions that advance a wide variety of...
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines
* CEPI supports up to 40 mil. USD for early development of mRNA vaccine platform to SK bioscience; up to a further 100 mil. could be made available for late-stage development. * SK bioscience to secure new vaccines and establish pandemic response system * SK bioscience to enhance human healt...
Clarivate Identifies Seven Innovators in New RNA Technology Companies to Watch Report
Report analyzes benefits, financing, R&D activity and more to reveal emerging standouts in medical science United States and Mainland China at the forefront of RNA technology advancement LONDON, Oct. 25, 2022 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in providing trusted inform...
MiRXES collaborates with Plug and Play to launch Southeast Asia's first science-backed commercialization engine and validator program
MiRXES Translator Program will accelerate revenue growth of start-ups and
importantly, adoption of preventive healthcare solutions globally
SINGAPORE, Oct. 25, 2022 /PRNewswire/ -- MiRXES
Week's Top Stories
Most Reposted
Earth Day 2024: Angel Yeast Continues to Tackle Plastic Pollution Challenges With Bio-based Material Solutions
[Picked up by 294 media titles]
2024-04-22 16:00Trina Solar and PetroGreen Partner to Accelerate Philippine Solar Adoption with 117MW Supply Agreement
[Picked up by 291 media titles]
2024-04-22 06:00Revenue Surpasses 50 Billion: BlueFocus Accelerates Towards the AI Native Era
[Picked up by 275 media titles]
2024-04-23 15:43INTAMSYS Becomes 3D Printing Equipment Supplier for the WORLDSKILLS LYON 2024 COMPETITION
[Picked up by 273 media titles]
2024-04-24 17:09Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever
[Picked up by 268 media titles]
2024-04-24 13:00